高级搜索
顺氯氨铂、丝裂霉素和平阳霉素联合治疗食管癌41例结果[J]. 肿瘤防治研究, 1991, 18(2): 109-110.
引用本文: 顺氯氨铂、丝裂霉素和平阳霉素联合治疗食管癌41例结果[J]. 肿瘤防治研究, 1991, 18(2): 109-110.
THE RESULTS OF 41 CASES ESOPHAGEAL CARCINOMA WITH COMBINATION CHEMOTHERAPY OF CISPLATIN, MITOMYCIN, AND PINGYANGMYCIN[J]. Cancer Research on Prevention and Treatment, 1991, 18(2): 109-110.
Citation: THE RESULTS OF 41 CASES ESOPHAGEAL CARCINOMA WITH COMBINATION CHEMOTHERAPY OF CISPLATIN, MITOMYCIN, AND PINGYANGMYCIN[J]. Cancer Research on Prevention and Treatment, 1991, 18(2): 109-110.

顺氯氨铂、丝裂霉素和平阳霉素联合治疗食管癌41例结果

THE RESULTS OF 41 CASES ESOPHAGEAL CARCINOMA WITH COMBINATION CHEMOTHERAPY OF CISPLATIN, MITOMYCIN, AND PINGYANGMYCIN

  • 摘要: 1986年7月~1987年12月采用顺氯氨铂、丝裂霉素、平阳霉素联合化疗治疗食管癌41例。完全缓解6例(14.6%),部分缓解17例(41.5%),微效9例(21.9%),稳定4例(9.8%),无效5例(12.2%)。完全缓解和部分缓解率(CR+PR)56.1%,总有效率(CR+PR+MR)78%,中位生存期7个月(2—32个月)。毒副反应有食欲减退,恶心、呕吐、脱发、发热、骨髓抑制。

     

    Abstract: From July 1988 to December 1987, 1st Affitiated Hospital of Henan Medical University, forty-one patients with esophageal carcinoma were treated by combination chemotherapy of cisplatin,mitomycin,and pingyangmycin. The treatment results showed that 8 cases (14,6%)of""complete remission, 9 cases (21.9%) of minimal response, 4 cases (9.8%) of stable and 5 cases (12.2%) of progression. The complete and partial remission rate (CR+PR) was 56.1% and the total response rate (CR+PR+MR) 78%.The median survival was 7 months (range 2-32 months).The toxicities seen were anorexia,nausea,vomiting, alopecia, hyperpyraxia, and mid myelodelodepressiof.

     

/

返回文章
返回